3 ms·
Yes, you want to contact them if some issue comes up which was not immediately clear.
by consp 6y ago
Yes, you want to contact them if some issue comes up which was not immediately clear.
- La1n 6y agoPfizer should not have this data, normally it doesn't leave the investigation site. Pfizer has only coded data (pseudoanonymous) that does have subject names replaced with numbers. edit: note that subjects can still be identified with this data, just not directly.
- mc32 6y agoCROs handle that data. Also adverse effects are strictly handled by third parties. This is likely an attempt at IP theft. Probably a second rate state actor.
- mft_ 6y agoCROs act as an agent of the Pharma company, so shouldn’t have it either. Patient identifiable information shouldn’t leave the investigator’s site.